Radiation Oncology · Published 2026-07-31 · DOI 10.1186/s13014-026-02902-0
Lanshan Li, Yuling Hong, Zhenyu Lin, Jianping Zhang, Benhua Xu, Zihan Zhou
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Li, L., Hong, Y., Lin, Z., et al. (2026). Pelvic bone marrow dosimetry predicts grade ≥ 2 hematologic adverse events in locally advanced rectal cancer. Radiation Oncology. https://doi.org/10.1186/s13014-026-02902-0